KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Atomera (ATOM) Research & Development: 2016-2025

Historic Research & Development for Atomera (ATOM) over the last 10 years, with Q3 2025 value amounting to $3.3 million.

  • Atomera's Research & Development rose 1975.35% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 1641.5%. This contributed to the annual value of $11.0 million for FY2024, which is 1194.41% down from last year.
  • According to the latest figures from Q3 2025, Atomera's Research & Development is $3.3 million, which was up 1975.35% from $3.0 million recorded in Q2 2025.
  • Over the past 5 years, Atomera's Research & Development peaked at $3.3 million during Q3 2023, and registered a low of $2.1 million during Q2 2021.
  • Moreover, its 5-year median value for Research & Development was $2.8 million (2024), whereas its average is $2.7 million.
  • In the last 5 years, Atomera's Research & Development surged by 3119.61% in 2023 and then crashed by 1889.1% in 2024.
  • Over the past 5 years, Atomera's Research & Development (Quarter) stood at $2.2 million in 2021, then increased by 12.18% to $2.5 million in 2022, then grew by 18.59% to $3.0 million in 2023, then dropped by 5.65% to $2.8 million in 2024, then increased by 17.04% to $3.3 million in 2025.
  • Its Research & Development stands at $3.3 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.3 million for Q1 2025.